Cancer gene hunt: mapping tumors to personalize treatment
NCT ID NCT03460483
Summary
This study aimed to screen endometrial cancer patients for specific genetic changes in their tumors to better understand their disease. By testing over 1,000 patients, researchers looked for inherited cancer risks and genetic markers that could predict how well treatments might work. The goal was to use this genetic information to create more personalized care plans and identify family members who might also be at risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aultman Health Foundation
Canton, Ohio, 44710, United States
-
Mercy Health - St. Vincent Medical Center
Toledo, Ohio, 43608, United States
-
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
-
Ohio Health
Columbus, Ohio, 43214, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
Summa Akron City Hospital/Cooper Cancer Center
Akron, Ohio, 44304, United States
-
TriHealth Cancer Institute-Westside
Cincinnati, Ohio, 45245, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Cincinnati
Cincinnati, Ohio, 45219, United States
Conditions
Explore the condition pages connected to this study.